Literature DB >> 29556828

Treatment of the Patient with Refractory Headache.

Alessandro S Zagami1.   

Abstract

PURPOSE OF REVIEW: To review recent studies outlining the management of refractory primary headache patients, including emerging therapies such as neuromodulation. This includes both noninvasive and invasive neuromodulation techniques. Recent studies on the management of medication overuse headache were also reviewed. RECENT
FINDINGS: There is no consensus as yet on the definitions of refractory chronic migraine and chronic cluster headache although there is broad agreement on some aspects of these terms. The importance of identifying medication overuse headache and dealing effectively with it has been highlighted in several studies although there is still not consensus on how best to achieve the cessation of medication overuse. Some recommend the use of preventative medication together with medication cessation, while others do not. Recent studies on neuromodulation have used both noninvasive vagal nerve stimulation as well invasive techniques. Recent studies using noninvasive vagal nerve stimulation for chronic migraine have been disappointing although the data in chronic cluster headache are more encouraging. Similarly, recent studies on occipital nerve stimulation have again been more positive in chronic cluster headache and generally negative in chronic migraine. In recent years, new forms of neuromodulation have emerged and long-term follow-up data from previous invasive neuromodulation techniques have become available. The sphenopalatine ganglion has been increasingly targeted by various interventions in several different headache types. Sphenopalatine ganglion stimulation is yielding encouraging data for the treatment of chronic cluster headache. New studies and long-term follow-up data from previous studies have provided further evidence for the benefit of deep brain stimulation for refractory chronic cluster headache although the exact target location is still debated. Data from phase 3 trials using CGRP monoclonal antibodies in chronic migraine and chronic cluster headache, if positive, may herald a long overdue, new and effective treatment for our refractory headache patients.

Entities:  

Keywords:  Chronic cluster headache; Chronic migraine; Medication overuse headache; Neuromodulation; Refractory headache

Mesh:

Substances:

Year:  2018        PMID: 29556828     DOI: 10.1007/s11916-018-0677-5

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  76 in total

1.  OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.

Authors:  S K Aurora; D W Dodick; C C Turkel; R E DeGryse; S D Silberstein; R B Lipton; H C Diener; M F Brin
Journal:  Cephalalgia       Date:  2010-03-17       Impact factor: 6.292

2.  Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial.

Authors:  Stewart Tepper; Messoud Ashina; Uwe Reuter; Jan L Brandes; David Doležil; Stephen Silberstein; Paul Winner; Dean Leonardi; Daniel Mikol; Robert Lenz
Journal:  Lancet Neurol       Date:  2017-04-28       Impact factor: 44.182

3.  Predictors of response to occipital nerve stimulation in refractory chronic headache.

Authors:  Sarah Miller; Laurence Watkins; Manjit Matharu
Journal:  Cephalalgia       Date:  2017-09-13       Impact factor: 6.292

4.  Ventral tegmental area deep brain stimulation for refractory chronic cluster headache.

Authors:  Harith Akram; Sarah Miller; Susie Lagrata; Jonathan Hyam; Marjan Jahanshahi; Marwan Hariz; Manjit Matharu; Ludvic Zrinzo
Journal:  Neurology       Date:  2016-03-30       Impact factor: 9.910

5.  Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

Authors:  H-C Diener; G Bussone; J C Van Oene; M Lahaye; S Schwalen; P J Goadsby
Journal:  Cephalalgia       Date:  2007-04-18       Impact factor: 6.292

6.  Chronic Bilateral Sphenopalatine Ganglion Stimulation for Intractable Bilateral Chronic Cluster Headache: A Case Report.

Authors:  Da-Wei Meng; Jian-Guo Zhang; Zhong Zheng; Xiu Wang; Fang Luo; Kai Zhang
Journal:  Pain Physician       Date:  2016-05       Impact factor: 4.965

7.  High-cervical spinal cord stimulation for medically intractable chronic migraine.

Authors:  Rinaldo De Agostino; Barbara Federspiel; Evaldas Cesnulis; Peter S Sandor
Journal:  Neuromodulation       Date:  2014-09-23

8.  Effects of non-invasive vagus nerve stimulation on attack frequency over time and expanded response rates in patients with chronic cluster headache: a post hoc analysis of the randomised, controlled PREVA study.

Authors:  Charly Gaul; Delphine Magis; Eric Liebler; Andreas Straube
Journal:  J Headache Pain       Date:  2017-02-14       Impact factor: 7.277

9.  Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic migraine.

Authors:  Daniel Fossum Bratbak; Ståle Nordgård; Lars Jacob Stovner; Mattias Linde; David W Dodick; Irina Aschehoug; Mari Folvik; Erling Tronvik
Journal:  Cephalalgia       Date:  2016-05-06       Impact factor: 6.292

10.  Refractory chronic migraine: a consensus statement on clinical definition from the European Headache Federation.

Authors:  Paolo Martelletti; Zaza Katsarava; Christian Lampl; Delphine Magis; Lars Bendtsen; Andrea Negro; Michael Bjørn Russell; Dimos-Dimitrios D Mitsikostas; Rigmor Højland Jensen
Journal:  J Headache Pain       Date:  2014-08-28       Impact factor: 7.277

View more
  1 in total

1.  Long-term efficacy of superficial temporal artery ligation and auriculotemporal nerve transection for temporal cluster headache in adolescent.

Authors:  Bowen Chang; Wanchun Zhu; Jin Zhu; Shiting Li
Journal:  Childs Nerv Syst       Date:  2019-07-09       Impact factor: 1.475

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.